Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2019 Earnings

6AugConfirmed

Q4 2018

Q1 2019

Q2 2019

Q3 2019

-9.06

-8.3

-7.54

-6.78

Details

Expected EPS

-7.9969779999999995

Actual EPS

-7.640676999999999

Surprise EPS

0.36

Surprise Percent

+4.46%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -7.640676999999999 per share for Q3 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.